BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18202755)

  • 1. Expression of p16INK4a and MIB-1 in relation to histopathology and HPV types in cervical adenocarcinoma.
    Muller S; Flores-Staino C; Skyldberg B; Hellström AC; Johansson B; Hagmar B; Wallin KL; Andersson S
    Int J Oncol; 2008 Feb; 32(2):333-40. PubMed ID: 18202755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
    Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
    J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations.
    Skyldberg BM; Murray E; Lambkin H; Kelehan P; Auer GU
    Mod Pathol; 1999 Jul; 12(7):675-82. PubMed ID: 10430271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
    Smith EM; Wang D; Kim Y; Rubenstein LM; Lee JH; Haugen TH; Turek LP
    Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group.
    Wentzensen N; du Bois A; Kommoss S; Pfisterer J; von Knebel Doeberitz M; Schmidt D; Kommoss F
    Int J Gynecol Pathol; 2008 Jan; 27(1):18-23. PubMed ID: 18156969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas.
    Ishikawa M; Fujii T; Masumoto N; Saito M; Mukai M; Nindl I; Ridder R; Fukuchi T; Kubushiro K; Tsukazaki K; Nozawa S
    Int J Gynecol Pathol; 2003 Oct; 22(4):378-85. PubMed ID: 14501820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16INK4A expression in cervical premalignant and malignant lesions.
    Lambert AP; Anschau F; Schmitt VM
    Exp Mol Pathol; 2006 Apr; 80(2):192-6. PubMed ID: 16257403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
    Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
    Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between human papilloma virus infection in cervical lesions and expression of p53, p21 proteins and Ki-67].
    Horikoshi M; Kina K; Ishi K; Izumi H; Kunii Y; Nojima M
    Rinsho Byori; 2005 Jun; 53(6):494-8. PubMed ID: 16026074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of P16INK4A and PTEN in high-risk human papillomavirus-related cervical cancer].
    Zhao XL; Cheng SX; Kong XD
    Ai Zheng; 2007 May; 26(5):480-3. PubMed ID: 17672936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
    Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
    J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16INK4a overexpression independent of human papillomavirus infection in lobular endocervical glandular hyperplasia.
    Hashi A; Xu JY; Kondo T; Hashi K; Yuminamochi T; Nara M; Murata S; Katoh R; Hoshi K
    Int J Gynecol Pathol; 2006 Apr; 25(2):187-94. PubMed ID: 16633071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms.
    Ronnett BM; Yemelyanova AV; Vang R; Gilks CB; Miller D; Gravitt PE; Kurman RJ
    Am J Surg Pathol; 2008 Dec; 32(12):1835-53. PubMed ID: 18813124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cell protein p16INK4a hyperexpression in epithelial malignancies induced by human papillomaviruses].
    Volgareva GM; Zavalishina LE; Andreeva IuIu; Shtil' AA; Frank GA
    Arkh Patol; 2008; 70(5):57-61. PubMed ID: 19137788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma.
    Missaoui N; Hmissa S; Frappart L; Trabelsi A; Ben Abdelkader A; Traore C; Mokni M; Yaacoubi MT; Korbi S
    Virchows Arch; 2006 May; 448(5):597-603. PubMed ID: 16496173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix.
    Horn LC; Lindner K; Szepankiewicz G; Edelmann J; Hentschel B; Tannapfel A; Bilek K; Liebert UG; Richter CE; Einenkel J; Leo C
    Int J Gynecol Pathol; 2006 Apr; 25(2):182-6. PubMed ID: 16633070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of adenocarcinoma of the cervix.
    Parker MF; Arroyo GF; Geradts J; Sabichi AL; Park RC; Taylor RR; Birrer MJ
    Gynecol Oncol; 1997 Feb; 64(2):242-51. PubMed ID: 9038270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
    Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG
    Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.